Opus: University of Bath Online Publication Store Are Multiple Physical Symptoms a Poor Prognostic Factor or Just a Marker of Depression Severity? Secondary Analysis of the Genpod Trial

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• COVID-19 and mental health: the other side of the coin

  2020cited by this paper
• Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals

  2014cited by this paper
• A high physical symptom count reduces the effectiveness of treatment for depression, independently of chronic medical conditions.

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Severity of depression and response to antidepressants: GENPOD randomised controlled trial

  2012cited by this paper
• Poor response to antidepressant medication of patients with depression accompanied by somatic symptomatology in the STAR*D Study.

  2011influential reference
• Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial

  2011cited by this paper
• Personalized medicine for depression: can we match patients with treatments?

  2010cited by this paper
• Adverse Effects of Multiple Physical Symptoms on the Course of Depressive and Anxiety Symptoms in Primary Care

  2010cited by this paper
• Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.

  2009cited by this paper
• Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.

  2008cited by this paper
• Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers

  2007cited by this paper
• Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

  2006cited by this paper
• Cytokines sing the blues: inflammation and the pathogenesis of depression.

  2006cited by this paper
• Does a depression intervention result in improved outcomes for patients presenting with physical symptoms?

  2004cited by this paper
• Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder.

  2004cited by this paper
• Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.

  2004cited by this paper
• The Association Between Anxiety, Depression, and Somatic Symptoms in a Large Population: The HUNT-II Study

  2004cited by this paper
• Impact of Pain on Depression Treatment Response in Primary Care

  2004influential reference
• Common pathways of depression and pain.

  2004cited by this paper
• Depression and pain comorbidity: a literature review.

  2003influential reference
• The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression.

  2003cited by this paper
• Somatic symptoms in treatment-resistant depression.

  2003cited by this paper
• Antidepressant Side Effects in Depression Patients Treated in a Naturalistic Setting: A Study of Bupropion, Moclobemide, Paroxetine, Sertraline, and Venlafaxine

  2002cited by this paper
• Evidence-based data on pain relief with antidepressants

  2000cited by this paper
• Role of norepinephrine in the pathophysiology and treatment of mood disorders.

  1999cited by this paper
• Psychosocial Care by General Practitioners—Where are the Problems? Results of a Demonstration Project on Quality Management in Psychosocial Primary Care

  1999cited by this paper
• Development and testing of the Medical Outcomes Study 36-Item Short Form Health Survey summary scale scores in the United Kingdom. Results from a large-scale survey and a clinical trial.

  1997cited by this paper
• Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy.

  1994cited by this paper
• Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

  1993cited by this paper
• The MOS social support survey.

  1991cited by this paper
• Predictors of placebo response in depression.

  1988cited by this paper
• The Hospital Anxiety and Depression Scale.

  1987cited by this paper
• Somatic presentation of DSM III psychiatric disorders in primary care.

  1985cited by this paper
• Depression: relationship to somatization and chronic medical illness.

  1984cited by this paper
• Depression in primary care: changes in pattern of patient visits and complaints during a developing depression.

  1978cited by this paper
• SCL-90: an outpatient psychiatric rating scale--preliminary report.

  1973cited by this paper
• An inventory for measuring depression.

  1961influential reference

• Astrocytes As the Main Players in Primary Degenerative Disorders of the Human Central Nervous System

  2016cites this paper